AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-172687142/simple-and-student-friendly.html" title="Facts and information about A simple and student-friendly approach to the mathematics of bond prices.(Author abstract)">A simple and student-friendly approach to the mathematics of bond prices.(Author abstract)</a>
Close
Set up an RSS feed that alerts you when new articles from Quarterly Journal of Business and Economics are available.
Frequently asked questions about RSS feeds
A simple and student-friendly approach to the mathematics of bond prices.(Author abstract)
Introduction
In his seminal paper Malkiel (1962) rigorously examined the relationship between the yield to maturity of bonds and their market prices. He developed and proved five theorems and showed how the relationship between the changes in yield to maturity and bond price movements depend on the coupon, the time to maturity, and the existing yield to maturity. Malkiel's (1962) five bond theorems have become the cornerstone in understanding the relationship between bond prices and their various determinants. There is no book that we are aware of dealing with bond prices and related topics that does not refer to these five theorems.
The original ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Inhibitex Initiates Phase I Trial of FV-100 for the Treatment of Shingles.
- Press release article from: Business Wire April 29, 2008 700+ words
...Continued Clinical Evaluation of Higher Doses of FV-100 on Track ATLANTA -- Inhibitex, Inc...Investigational New Drug application (IND) for FV-100, its oral nucleoside analogue in...of up to four single ascending doses of FV-100 in healthy subjects. Each dose cohort...
- Inhibitex Presents Encouraging Phase I Data on FV-100 At 21st International...
- Press release article from: Business Wire April 15, 2008 700+ words
...presenting data from a Phase I clinical study of FV-100, a highly potent antiviral compound...our initial single ascending dose study of FV-100 in healthy volunteers," stated Dr...The pharmacokinetic data suggest that FV-100, which is a prodrug, is rapidly...
- Inhibitex Completes Phase I Clinical Trials for FV-100 and Selects Lead HCV...
- Press release article from: Business Wire February 9, 2009 700+ words
...Support Evaluation of Once-Daily Dosing of FV-100 in Phase II ATLANTA -- Inhibitex...completed its Phase I clinical trials of FV-100, a highly potent and fast-acting...and pharmacokinetics of five oral doses of FV-100 (100, 200, 400 and 800 mg administered...
- Inhibitex Reports Initiation of Multiple Ascending Dose Trial of FV-100 for...
- Press release article from: Business Wire August 6, 2008 700+ words
...multiple ascending dose (MAD) trial of FV-100, a highly potent and fast-acting...safety and pharmacokinetics of four doses of FV-100 in five cohorts of healthy volunteers...consisted of six subjects that received FV-100 and two that received placebo. The...
- Inhibitex Initiates Phase II Clinical Trial of FV-100 for the Treatment of...
- Press release article from: Business Wire May 8, 2009 700+ words
...initiated a Phase II clinical trial with FV-100, its oral antiviral compound in clinical...controlled, double-blind study evaluating FV-100 against an active control (valacyclovir...to one of three treatment arms: 200 mg FV-100 administered once daily; 400 mg FV...
- Preclinical Data on FermaVir's FV-100 Presented at the 47th Annual Interscience...
- Press release article from: Business Wire September 19, 2007 700+ words
...presented data from preclinical studies for FV-100, a highly potent, orally bioavailable...antiviral and pharmacokinetic properties for FV-100, including the compound's bioavailability...Zoster Virus (VZV). "These data on FV-100 provide further evidence of the compound...
- Inhibitex Reports Favorable Results from First Clinical Trial of...
- Press release article from: Business Wire December 14, 2007 700+ words
...completed its initial Phase I clinical trial of FV-100, a nucleoside analogue being developed...pharmacokinetics of three oral doses of FV-100 (10, 20 and 40 mg) in healthy volunteers...consisted of six subjects that received FV-100 and two that received placebo. The...
- Structural analysis of anti-HIV monoclonal antibody 447-52D Fv feasible.
- Newspaper article from: Biotech Week August 6, 2003 700+ words
...anti-HIV monoclonal antibody 447-52D Fv is feasible, thanks to a novel E. coli-based expression model. "The Fv is the smallest antigen binding fragment...researchers in Israel explained. "The 26-kDa Fv is amenable for structure determination...
